Seattle Genetics Inc (NASDAQ:SGEN)

45.30
Delayed Data
As of Aug 26
 +1.32 / +3.00%
Today’s Change
26.02
Today|||52-Week Range
49.66
+0.94%
Year-to-Date
No recent news for Seattle Genetics Inc.

Today’s Trading

Previous close43.98
Today’s open44.14
Day’s range43.71 - 45.32
Volume652,569
Average volume (3 months)811,235
Market cap$6.2B
Dividend yield--
Data as of 3:59pm ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)-50.00%
Earnings growth (this year)-7.91%
Earnings growth (next 5 years)-28.70%
Revenue growth (last year)+17.45%
P/E ratioNM
Price/Sales17.21
Price/Book8.96

Competitors

 Today’s
change
Today’s
% change
ALNYAlnylam Pharmaceutic...+1.45+2.09%
ALKSAlkermes Plc+0.33+0.75%
TAROTaro Pharmaceutical ...+1.52+1.20%
UTHRUnited Therapeutics ...-1.50-1.22%
Data as of 4:02pm ET, 08/26/2016

Financials

Next reporting dateOctober 27, 2016
EPS forecast (this quarter)-$0.29
Annual revenue (last year)$336.8M
Annual profit (last year)-$120.5M
Net profit margin-35.77%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Clay B. Siegall
Chief Operating Officer
Eric L. Dobmeier
Corporate headquarters
Bothell, Washington

Forecasts

Partner Offers

NextAdvisor